James K. Min, MD, FACC is the founder and CEO of Cleerly, a mission-driven healthcare company whose digital care pathway supports physicians and patients by reducing risk of heart attacks. Previously, Min served as a full professor of Radiology and Medicine (Cardiology) at the Weill Cornell Medical College and Director of the Dalio Institute of Cardiovascular Imaging at the NewYork-Presbyterian Hospital. Min has worked with the American College of Cardiology, leading on the Task Force for Appropriate Use Criteria and Expert Consensus Documents, and the Society of Cardiovascular Computed Tomography as its president and the chair of the Scientific Sessions. Min served as the editor-in-chief of the Journal of Cardiovascular Computed Tomography and associate editor for the Journal of the American College of Cardiology, Cardiovascular Imaging. Min has led >10 prospective multicenter clinical trials and served as the director of the CT Core Laboratory for the ISCHEMIA trial.
To improve heart attack prevention, there is an urgent unmet need to modernize our approach from late-stage symptom-driven care to direct disease-based care, a care paradigm that addresses heart attack risk in all patients across the entire continuum of heart disease severity.